Acupressure for Eczema: A Small Itch Signal Did Not Mean the Overall EASI Score Improved
DOCTOR’S NOTES · ECZEMA EVIDENCE
A brief self-administered technique may appeal to someone whose eczema itch intrudes during work or after exercise. Before interpreting acupressure research as a treatment promise, separate the patient’s itch rating from the overall clinical severity score. A small pilot found that those outcomes did not move together.
What was tested
Lee and colleagues’ March 2012 primary abstract reports 15 adults enrolled, with 12 completing four weeks. Participants were randomized to acupressure plus standard care or standard care alone. The protocol used an acupellet at the LI11 point; it was not a trial of acupuncture needles or of arbitrary rubbing over an eczema patch.
| Reported comparison between groups | Finding |
|---|---|
| Itch visual-analogue score | Greater decrease with acupressure; P=.04. |
| Investigator global assessment | A favorable signal; P=.03. |
| EASI lichenification component | A favorable signal; P=.03. |
| Overall EASI | No significant change established. |
The publisher’s primary abstract describes the findings as preliminary and calls for larger studies. It does not supply a robust effect-size estimate or confidence interval for a precise expectation of personal benefit. We do not manufacture those missing quantities from P values.
A component is not the entire disease score
Lichenification refers to thickened skin associated with repeated rubbing or scratching. An improvement in that component need not imply a substantial change in all signs or in the extent of eczema. Likewise, a reported itch improvement can be meaningful to a person without proving overall inflammatory disease control.
The correct interpretation retains both observations: a possible symptom-related signal and the unchanged overall EASI result. Replacing that with a broad “eczema improved” claim would blur the distinction the trial itself makes.
What the comparator cannot rule out
Standard care alone is a useful comparison, but it is not a sham procedure matching touch, attention or expectation. With only 12 completers, individual outcomes can have a large influence. The abstract does not justify claiming that the specific point or pellet accounts for every difference, or that the findings generalize to infants.
Fit any adjunct into a clear care plan
Ask the treating clinician whether a proposed technique is appropriate for the individual and how it would be used alongside established treatment. Clarify whether the intended goal is coping with itch or control of visible disease. Avoid substituting forceful rubbing or pressure on damaged skin for the studied technique.
Keep a brief record of what actually changes: itch interruption, scratching, sleep or visible patches. A convenient activity should not delay review of worsening eczema, and absence of a large study is not a reason to promise universal safety. The AAD guideline hub is the broader reference for clinical treatment.
Compare another adjunctive approach whose small studies need careful interpretation
Where moisture care fits
Dr. Arsy Moisturizer #003, 4 oz (120 g) is a cosmetic moisturizer for hydration, moisture-barrier support and dry-skin comfort. It does not treat, cure or prevent eczema and was not tested in the research discussed here. These findings do not establish pediatric efficacy or infant suitability for #003; ask a child’s clinician about an appropriate moisturizer.
Continue with a related question
- How to Read an Eczema Study Without Getting Misled by Percentages
- Your Eczema Itch Score and Your Rash Score Can Tell Different Stories
- What Is SCORAD? Understanding an Eczema Severity Score
Prepared by the Dr. Arsy editorial team. Sources checked November 9, 2026. Educational content does not diagnose an individual or imply independent medical review. Cited researchers and institutions do not endorse #003. Image is an AI-created editorial product illustration, not a patient photograph or clinical result.